Leading Biomedical industry and Research-Based Groups Launch Coalition against AMR Resistance
Originally published on the Canadian Antimicrobial Innovation Coalition (CAIC) website. To mark World Antimicrobial Awareness Week,...
top of page
Jun 7, 2018
Canadian Declaration on Antimicrobial Resistance: Addressing the Multiple Challenges of AMR
Public awareness is growing in Canada and around the world about the urgent need for concerted global action to counter the serious...
Jan 16, 2017
Fedora Pharmaceuticals Receives Support from the Government of Canada to Battle AMR
EDMONTON, Alberta – Fedora Pharmaceuticals, Inc. announced they have received nonrefundable financial contribution from the National...
Feb 10, 2016
Super drugs for superbugs: Edmonton firm wins largest biotech licensing deal in Canadian history
Originally published on the National Research Council of Canada. EDMONTON, Alberta - Doctors around the world are starting to speak with...
Jan 5, 2016
Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating AMR
Originally published on the Review on Antimicrobial Resistance. Antimicrobials, and specifically antibiotics, play a crucial role in...
Nov 30, 2015
Fedora Pharmaceuticals Receives Alberta Life Sciences "Company of the Year" Award
EDMONTON, Alberta - Fedora Pharmaceuticals Receives Alberta Life Sciences "Company of the Year" Award EDMONTON, Alberta – November 30,...
Nov 9, 2015
Fedora Pharmaceuticals Inc. Receives 2015 ASTech Award for Outstanding Commercial Achievement
EDMONTON, Alberta – November 9, 2015 – Fedora Pharmaceuticals Inc., a biotechnology company headquartered in Edmonton, Alberta, Canada,...
Jan 13, 2015
Roche, Meiji and Fedora join forces to tackle increasing bacterial resistance to antibiotics
Originally published on Roche.com BASEL, Switzerland - Roche (SIX: RO, ROG; OTCQX: RHHBY), Meiji Seika Pharma (Meiji) and Fedora...
Sep 12, 2013
FPI-1465 Increases Activity of Certain Antibiotics against Drug-Resistant Bacteria
Findings Presented at Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) EDMONTON, Alberta – September 12, 2013 –...
Oct 30, 2012
Fedora Pharmaceuticals Appoints Ronald Odynski and Dr. Leonard Post to Board of Directors
EDMONTON, Alberta – October 31, 2012 – Fedora Pharmaceuticals, Inc. today announced the creation of a Board of Directors and appointment...
Sep 4, 2012
Fedora Pharmaceuticals Appoints Thomas R. Parr, Ph.D., Chief Scientific Officer
EDMONTON, Alberta – September 5, 2012 – Fedora Pharmaceuticals, Inc. today announced the appointment of Thomas Parr, Ph.D. to the newly...
bottom of page